Home Latest Articles
Latest Articles
  • Shigang WANG, Longhai ZHANG, Fang JI, Runhua YANG
    World Clinical Drug. 2023, 44(4): 324-330.
    Objective

    To explore the effect of bifidobacterium combined with blood purification and auxiliary antibiotics in the treatment of patients with sepsis.

    Methods

    Ninety patients with sepsis in our hospital were selected and divided into control group and study group according to the random number table method, 45 cases in each group. The control group was treated with antibiotics and blood purification, and the study group was given bifidobacterium on the basis of the control group. The therapeutic effect, acute physiology and chronic health evaluation Ⅱ (APACHE Ⅱ), C-reactive protein (CRP), procalcitonin (PCT), tumor necrosis factor-α(TNF-α), high mobility group protein B1 (HMGB1), intestinal flora, humoral immune indexes [immunoglobulin (Ig) A, IgM, IgG], cellular immune indexes and adverse reactions were compared between the two groups before and after treatment.

    Results

    The total effective rate of the study group (88.89%) was higher than that of the control group (80.00%, P>0.05). APACHE Ⅱ score in the study group was lower than that in the control group after 7 d of treatment. The serum CRP, PCT, TNF-α, HMGB1 and CD8+ in the study group were lower than those in the control group after 3 d and 7 d of treatment (P<0.05). The number of lactobacillus, bifidobacterium and bacteroidetes in the study group were more than those in the control group, staphylococcus was less than that in the control group (P<0.05). Serum IgA, IgM, IgG, CD3+, CD4+, CD4+/CD8+ in the study group were higher than those in the control group after 3 d and 7 d of treatment (P<0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05).

    Conclusion

    Bifidobacterium combined with blood purification and auxiliary antibiotics can improve the efficacy to a certain extent in the treatment of patients with sepsis. It can accelerate the recovery of the disease, reduce inflammatory response, regulate intestinal flora, improve body fluid and cellular immunity, and does not increase adverse drug reactions.

  • Kai FU, Yonghui WANG, Le KANG, Jing ZHOU, Yao MENG, Xiaoling WANG
    World Clinical Drug. 2023, 44(4): 331-336.
    Objective

    To evaluate the effect and safety of ceftazidime/avibactam (CAZ/AVI) in the salvage treatment of carbapenem-resistant Klebsiella pneumoni (CRKP) infection in premature infants.

    Methods

    Clinical data of 12 premature infants with CRKP infection who received salvage CAZ/AVI therapy from August 2020 to July 2022 were retrospectively analyzed. They were divided into combination group (n=5) and monotherapy group (n=7) according to whether CAZ/AVI was combined with meropenem or not. Clinical data, medication information, laboratory test results and adverse reactions of all infants were recorded.

    Results

    There were 5 cases of bloodstream infection and 7 cases of pulmonary infection. When delayed infusion of high dose meropenem or combined with fosfomycin was not effective, off-prescription CAZ/AVI salvage therapy was used, the average treatment time was (12.00±4.73) d, and the overall cure rate was 66.67%.

    Conclusion

    CAZ/AVI is effective and safe in the treatment of CRKP infection in premature infants, and can be used as an alternative treatment.

  • Biao ZHAO, Meng WU, Yundong ZHANG
    World Clinical Drug. 2023, 44(4): 337-343.
    Objective

    To investigate the efficacy of troxerutin combined with argatroban on acute ischemic stroke (AIS) patients and its effects on serum levels of high sensitivity C-reactive protein (hs-CRP), matrix metalloproteinase-9 (MMP-9) and soluble CD40 ligand (sCD40L).

    Methods

    A total of 108 AIS patients admitted to our hospital from March 2019 to March 2022 were selected and randomly divided into control group and observation group by random number table method, with 54 patients in each group. The control group was treated with argatroban anticoagulant therapy, and the observation group was treated with troxerutin combined with argatroban, and the course of treatment was 7 days. The efficacy, cerebral blood flow (CBF), cerebral blood volume (CBV), neurological function, quality of life, serum hS-CRP, MMP-9 and sCD40L levels, the incidence of complications and adverse reactions were compared between the two groups.

    Results

    Both groups successfully completed the treatment. The total effective rate of the observation group was higher than that of the control group (92.59% vs 75.93%, χ2=4.468, P<0.05). After treatment, the scores of National Institutes of Health stroke scale [(8.24±2.65) vs (10.21±3.12)] and modified Rankin scale score [(2.05±0.23) vs (3.21±0.71] in the observation group were lower than those in the control group (P<0.05). The Barthel index [(75.36±15.09) vs (69.20±13.48)], CBF [(72.51±21.35) mL/100 mg vs (62.42±19.35)mL/100 mg] and CBV [(95.36±25.66) mL/100 mg vs (83.20±22.48) mL/100 mg] in the observation group were higher than those in the control group (P<0.05). The levels of hS-CRP [(2.34±0.52)mg/L vs (4.02±1.09)mg/L], MMP-9[(3.02±0.64)μg/L vs (5.16±1.39)μg/L] and sCD40L [(150.29±20.92)pg/mL vs (196.35±35.12)pg/mL] in the observation group were lower than those in the control group (P<0.05).

    Conclusion

    Compared with argatroban alone, troxerutin combined with argatroban in the treatment of AIS can significantly reduce serum hS-CRP, MMP-9 and sCD40L levels, improve cerebral blood perfusion and neurological function, and improve quality of life.

  • Xiaozhou GUO, Guobing CAI
    World Clinical Drug. 2023, 44(4): 344-348.
    Objective

    To analyze the effects of dexmedetomidine (DEX) combined with sevoflurane on emergence agitation (EA) and postoperative cognitive dysfunction (POCD) in patients with total knee arthroplasty (TKA).

    Methods

    Clinical data of 169 TKA patients admitted to the department of orthopedics, Mingguang hospital of traditional Chinese medicine from October 2019 to December 2021 were included. According to the anesthesia method, they were divided into combined anesthesia group (n=85, DEX+sevoflurane) and sevoflurane group (n=84, sevoflurane). The operation time, intraoperative blood loss, anesthesia recovery time, respiratory recovery time and extubation time of the two groups were observed. Riker sedation-agitation scale (SAS), Montreal cognitive assessment (MoCA) and confusion assessment method (CAM) were used to evaluate EA, POCD and other postoperative adverse events in the two groups.

    Results

    The anesthesia recovery time, respiratory recovery time and extubation time of the combined anesthesia group were significantly lower than those of the sevoflurane group (P<0.05). The amount of rocuronium bromide and remifentanil in combined anesthesia group was less than that in the sevoflurane group (P<0.05). Five patients in the combined anesthesia group showed EA, which was lower than that in the sevoflurane group (13 cases), and the difference was statistically significant (P<0.05). The SAS score of the combined anesthesia group was lower than that of the sevoflurane group, and the difference was statistically significant (P<0.01). The MoCA score of combined anesthesia group was higher than that of sevoflurane group on D1 after surgery, and the difference was statistically significant (P<0.001). The incidence of hypotension and bradycardia in combined anesthesia group was higher than that in sevoflurane group, while the incidence of POCD was lower than that in sevoflurane group, and the difference was statistically significant (P<0.05).

    Conclusion

    DEX combined with sevoflurane can effectively reduce the incidence of EA and adverse events in patients with TKA, and improve postoperative cognitive function.

  • Xiaoguang GUO, Guangli LI
    World Clinical Drug. 2023, 44(4): 349-354.
    Objective

    To investigate the effects of three anesthesia regimens on postoperative pain and prognosis after internal fixation in elderly patients with distal fracture of radius.

    Methods

    A total of 59 elderly patients with distal fracture of radius undergoing internal fixation in Department of Orthopedics, the first affiliated hospital of Zhengzhou university from January 2017 to October 2021 were selected. According to anesthesia, they were divided into general anesthesia (GA) group, ultrasound-guided brachial plexus block (BPB) group and wide-awake local anesthesia no tourniquet (WALANT) group. The operation time, intraoperative blood loss, anesthesia resuscitation room time, hospitalization time, hospitalization cost, visual analogue scale (VAS) score, anesthesia satisfaction and the occurrence of adverse reactions in the three groups were observed. Fracture healing time, Mayo wrist function score and patient-rated wrist evaluation (PRWE) were followed up.

    Results

    The intraoperative blood loss in WALANT group was higher than that in GA group and BPB group, and the difference was statistically significant (P<0.05). The anesthesia resuscitation room time of GA group was longer than that of BPB group and WALANT group, and the difference was statistically significant (P<0.05). At 6 - 12 h after surgery, VAS scores of the three groups from high to low were GA group, BPB group and WALANT group, with statistical significance (P<0.05). The incidence of adverse reactions in GA group was higher than that in WALANT group and BPB group, with statistical significance (P<0.05). All patients were followed up, and the fracture healing time ranged from 8 to 11 weeks, with a mean of (9.58±1.43) weeks. There was no statistical significance in fracture healing time, Mayo wrist function score and PRWE score among the three groups (P>0.05).

    Conclusion

    WALANT technique can significantly relieve postoperative pain, reduce postoperative complications and hospitalization costs in elderly patients after internal fixation of distal radius fracture.

  • Chunying CHEN, Xiaotian XIE
    World Clinical Drug. 2023, 44(4): 355-361.
    Objective

    To explore the clinical characteristics of MPL mutation-related congenital amegakaryocytic thrombocytopenia (CAMT).

    Methods

    Typical cases of CAMT were summarized by referring to the common confirmation method used in rare disease research. A total of 85 cases of clinical data from 46 literatures at home and abroad were collected since 2010. Statistical analysis was performed to show the clinical characteristics and diagnosis and treatment effect of CAMT.

    Results

    The main characteristics of CAMT were summarized as follows. The proportion of female patients was higher than that of male patients (1.67∶1), the onset age was earlier (average 12.1 months), and the diagnosis age was delayed (average 46 months). These cases mainly presented with skin and mucous membrane hemorrhage, but 22 cases had intracranial hemorrhage, of which 4 cases had intrauterine intracranial hemorrhage. All patients had decreased peripheral blood plaques (1.0×109/L - 83.0×109/L). MPL gene mutation was presented in all patients, including homozygous 52 cases and complex heterozygous 33 cases. There was a significant trend of pancytopenia. The plasma thrombopoietin (TPO) level was significantly increased, with an average of 1 505.8 pg/ml. Non-hematopoietic system abnormalities up to 52%. The only radical treatment is allogeneic hematopoietic stem cell transplantation (allo-HSCT), and TPO agonists are alternative drugs for children lacking allo-HSCT condition.

    Conclusion

    The onset of CAMT in the neonatal period or early infant without other special manifestations, so it is easy to be misdiagnosed. Almost all CAMTs may progress to triple hemocytosis with typical aplastic anemia. Aitripopal and romisteine can be used as drugs to replace allo-HSCT.

  • Chaoping WANG, Xu ZHOU, Jiluo ZHANG, Sen CHEN, Zhenzhen ZHANG
    World Clinical Drug. 2023, 44(4): 362-367.
    Objective

    To investigate the influence of permissive hypercapnia (PHC) on obese patients undergoing shoulder arthroscopic surgery with beach chair position (BCP).

    Methods

    Sixty-seven patients with body mass index≥28 kg/m2 who received shoulder arthroscopic surgery in the Department of joint surgery, Luoyang orthopedic-traumatological hospital of Henan province from January 2019 to January 2021 were enrolled and randomly divided into observation group and control group by random number table method. The partial pressure of end-tidal carbon dioxide (PetCO2) was 45 -50 mmHg in the observation group and 30 - 35 mmHg in the control group. The observation time points were before anesthesia induction (T0), 10 min after BCP modification (T1), 10 min after controlled hypotension (T2), 10 min after ventilation strategy modification (T3), and 10 min after supine position modification (T4). Mean arterial pressure (MAP), cerebral oxygen saturation (rSO2), hypotension, delirium, rSO2 descent event (CDE), and postoperative D1 and D3 minimental state examination (MMSE) score were compared between the two groups.

    Results

    MAP of the two groups at T1, T2 and T3 were lower than those at T0, and the differences were statistically significant (P<0.05). RSO2 levels at T2 in the two groups decreased by 16.84% and 21.51%, respectively, and there were statistically significant differences compared with T0 (P<0.05). RSO2 levels at T3 and T4 in observation group were higher than those in control group, and the differences were statistically significant (P<0.05). MMSE score of observation group was significantly higher than that of control group, and the difference was statistically significant (P<0.05).

    Conclusion

    PHC can ensure stable rSO2 level in obese patients during shoulder arthroscopic surgery with BCP and reduce the risk of postoperative delirium and other complications.

  • Xiuying GUAN, Peng JIA, Jianzhong HUANG, Hongbin ZHANG, Zechang RAO, Chunxiang CHEN
    World Clinical Drug. 2023, 44(4): 368-374.

    Interleukin (IL)-6 is a typical inflammatory cytokine with complex biological characteristics. In recent years, many studies have found that the abnormal expression of IL-6 is observed in the occurrence and development of various diseases. Therefore, it is speculated that monitoring the changes of IL-6 level in diseases may be helpful for the early diagnosis and prevention of diseases, as well as the evaluation of therapeutic effect. Therefore, this article reviewed the biological characteristics of IL-6 and the correlation between its abnormal expression and the occurrence and development of diseases, in order to provide a certain reference for the selection of clinical treatment strategies.

  • Jun WANG, Yidan YAN, Hao TANG, Yingjie SU
    World Clinical Drug. 2023, 44(4): 375-378.

    Vascular endothelial growth factor (VEGF) and its receptor (VEGFR) play a crucial role in physiological and pathological angiogenesis. Since the growth of malignant tumors cannot be separated from the support of neovascularization, anti-tumor angiogenesis drugs that inhibit VEGF/VEGFR system have become one of the important means of tumor drug therapy. With the wide application of drugs in clinical practice, nephrotoxicity manifested as proteinuria occurs in some patients during the course of medication, and its pathogenesis is still unclear. This article reviews the incidence, mechanism, clinical diagnosis and treatment of proteinuria induced by the clinical use of anti-tumor angiogenesis drugs, in order to provide reference for clinical medication.

  • Bowen LIU, Hua YANG, Tengfei WU, Yilei CONG, Xinyu YANG, Yirong CHEN
    World Clinical Drug. 2023, 44(4): 379-383.

    Vascular endothelial function is an important safeguard for maintaining vascular permeability, balancing coagulation and fibrinolytic systems, and limiting inflammatory activities. Vascular endothelial dysfunction can lead to the occurrence and development of a series of diseases, especially diabetes mellitus (DM). Vascular endothelial dysfunction is considered to be an early event of vascular disease in DM, and the damage of vascular endothelial cells runs through the occurrence and development of DM and its complications. This article reviewed the research progress on the correlation between vascular endothelial function and type 2 DM and traditional Chinese medicine syndromes, aiming to provide some reference for clinical practice.

News